tiprankstipranks
Cartesian announces Phase 2b trial of Descartes-08 achieved primary endpoint
PremiumThe FlyCartesian announces Phase 2b trial of Descartes-08 achieved primary endpoint
1M ago
Cartesian Therapeutics announces employment inducement grant
Premium
The Fly
Cartesian Therapeutics announces employment inducement grant
2M ago
Three new option listings and eighteen option delistings on September 23rd
Premium
The Fly
Three new option listings and eighteen option delistings on September 23rd
2M ago
Cartesian Therapeutics Engages Investors at Conferences
PremiumCompany AnnouncementsCartesian Therapeutics Engages Investors at Conferences
4M ago
Cartesian Therapeutics reports Q2 EPS 54c, consensus ($1.07)
Premium
The Fly
Cartesian Therapeutics reports Q2 EPS 54c, consensus ($1.07)
4M ago
Nvidia, Crowdstrike upgraded: Wall Street’s top analyst calls
Premium
The Fly
Nvidia, Crowdstrike upgraded: Wall Street’s top analyst calls
4M ago
Cartesian Therapeutics downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyCartesian Therapeutics downgraded to Perform from Outperform at Oppenheimer
5M ago
Cartesian Therapeutics: Investment, Director Appointment, and Trial Success
Premium
Company Announcements
Cartesian Therapeutics: Investment, Director Appointment, and Trial Success
5M ago
Cartesian Therapeutics announces $130M private placement equity financing
Premium
The Fly
Cartesian Therapeutics announces $130M private placement equity financing
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100